Rare Diseases and Orphan Drugs Global Forum 2017 - 1st and 2nd November 2017 - Crowne Plaza Hotel Belgrade
Speakers
Cesare Spadoni
Chairman
aPODD Fundation
Malcolm Allison
Director and Owner
InterComm International Ltd
Karen Frascello
VP of Business Development
Caligor Opco LLC
Christian Girard
Corporate Advisor
Advisory & Intelligence
Gulce Belgin
General Manager
Luna Pharma Consulting Ltd
Benoit ARNOULD, Ph.D.
Senior Director
Mapi Group
Key Parkinson
CEO
Cambridge Rare Disease Network
Goran Medic
Market Access Manager Europe
Chiesi Farmaceutici S.p.A.
Eda Selebatso
Founder & Chairperson
BORDIS
Tanya Collin-Histed
CEO
European Gaucher Alliance
Lutz Harnisch
Senior Director
Pfizer
ALASTAIR KENT OBE
Director
Genetic Alliance UK
Jama Nateqi
Co-Founder
SYMPTOMA
Larissa Kerecuk
Rare Disease Lead
Birmingham Children's Hospital
Jeff Davis
Chief Business Officer
Acer Therapeutics, Inc.
Dan Jeffries
Patient
Wyburn-Mason syndrome
Pete Chan
Head of Research & Analysis
Raremark
Frans van Andel, MSc, MPH, PhD
Board Director
PPi Healthcare Consulting Ltd
Dr Yves Cariou
Country Director for France
PPi Healthcare Consulting Ltd